RG
ONC

Redmile Group’s BeOne Medicines Ltd ONC Stock Holding History

Redmile Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-39,900
Closed -$4.95M – 83
2019
Q2 		$4.95M Sell
39,900
-500
-1% -$63.5K 0.14% 64
2019
Q1 		$5.33M Hold
40,400
– – 0.16% 62
2018
Q4 		$5.67M Buy
40,400
+100
+0.2% +$13.3K 0.23% 60
2018
Q3 		$6.94M Hold
40,300
– – 0.21% 62
2018
Q2 		$6.2M Buy
40,300
+300
+0.8% +$53.5K 0.21% 58
2018
Q1 		$6.72M Buy
+40,000
New +$5.42M 0.26% 54

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Redmile Group's ONC Position: Q3 2019 in Review

Redmile Group sold out of BeOne Medicines Ltd (ONC) in Q3 2019, closing a stake of 39,900 shares — an estimated $4.95M sold.

Redmile Group first reported a position in ONC in Q1 2018 and held it in 6 quarters. The position peaked at $6.94M in Q3 2018. 196 funds tracked by Wall St. Rank hold ONC as of Q3 2019.

  • Redmile Group reported no remaining BeOne Medicines Ltd position as of Q3 2019 after selling out during the quarter.
  • Redmile Group sold 39,900 BeOne Medicines Ltd shares in Q3 2019, an estimated $4.95M.
  • Redmile Group first reported a position in BeOne Medicines Ltd in Q1 2018 and held it in 6 quarters.
  • Redmile Group's BeOne Medicines Ltd position peaked at $6.94M in Q3 2018.
  • 196 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2019.

Based on Redmile Group's 13F filing for Q3 2019, filed 14 Nov 2019.